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Brazil’s large size (more than 8.5 million km2
and 150 million population) and inadequate
public health infrastructure pose a considerable
challenge in assessing the status of emerging
infectious diseases. Under the current system,
most infectious diseases are not notifiable. In
diseases for which notification is required,
underreporting is common and varies widely by
region and disease, and notification is often
delayed, which causes the data to be revised
frequently. Moreover, in hospital and clinical
settings, the etiologic agent of an infectious
disease is often not identified. For example, more
than a million hospital admissions are recorded
per year by the public health system under
parasitic and infectious diseases (the category
excludes AIDS and respiratory illnesses); of these
diseases, more than 70% are diagnosed as ill-
defined intestinal infections and a further 10% as
food poisoning and septicemia, both without
identification of the etiologic agents. For these
reasons, the numbers reported here (1996 data,
unless otherwise stated) may not reflect the true
numbers of cases, and only diseases whose
prevalence has changed markedly in recent years
will be included in the review.
Parasitic Diseases
Malaria
Among parasitic diseases, malaria causes the
most illness, approximately half a million cases
annually, nearly all from the northern (Amazon)
region. The disease has been controlled in the
remainder of the country for years. Where
systematic and sustained efforts have been made
in the Amazon, control has also been successful.
Due to the different epidemiologic situations in
the Amazon, no single strategy is effective.
Worrying developments in this region include the
establishment of the disease in the periphery of
the principal cities and the increase in drug-
resistant parasites.
American Trypanosomiasis
American trypanosomiasis (Chagas disease)
is the most lethal parasitic disease in Brazil,
causing more than 5,000 deaths per year. Several
million people are chronically infected carriers of
this disease, for which there is still no effective
treatment. A very effective control program against
the principal insect vector, Triatoma infestans, and
improved control of the blood supply have reduced
the incidence of new cases to a very low level.
Factors that continue to make the disease a re-
emerging threat include secondary vectors, forest
clearance, and congenital transmission.
Leishmaniasis
Leishmaniasis (cutaneous and visceral) has
increased in incidence in recent years. This
increase is modified by apparent cyclic variations
of undetermined cause (cyclic duration for the
visceral form has been estimated at 10 years).
The disease has increased not only in the usual
areas of forest and recent clearance, but also in
areas of traditional colonization as well as in the
urban areas of the northeast. One factor involved
in the spread of this disease, uncontrolled urban
growth due principally to rural migration, has led
to pockets (normally on the periphery of the
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cities) of extreme poverty that favor the
spread of many diseases.
Viral Diseases
Dengue
Among the notifiable viral diseases, dengue
causes the most illness. Its mosquito vector,
Aedes aegypti, was reintroduced into Brazil in the
1970s; large outbreaks followed in the next
decade. Since the vector’s reintroduction, more
than 700,000 cases have been reported (180,000
cases in 1996). The presence of dengue-1 and -2
indicates that cases of hemorrhagic dengue are
also occurring. Ae. aegypti is now present in all
states, and a plan has been formulated by the
federal ministry of health to eradicate the vector,
although plan implementation has met with
operational difficulties. The widespread distribu-
tion of Ae. aegypti, also the vector of yellow fever,
in areas where this disease was considered
endemic poses a serious risk for the reemergence
of the epidemic form of yellow fever. Vaccination
and sanitation campaigns earlier in the century
considerably reduced the incidence of the disease
(fewer than 100 cases per year—the last urban
cases were reported in 1942).
Measles
Measles—a viral disease that was controlled
and nearly eradicated—reemerged with a
vengeance in 1997. The outbreak began in the
state of São Paulo, where only 15 cases of measles
were confirmed in 1996, and has spread to other
states. As of October 1997, 61,000 cases (48,000 in
São Paulo) have been reported, and 17,000
(13,000 in São Paulo) have been confirmed. Most
cases have occurred in young adults under 30
years of age. The vaccination campaign has been
reformulated in response to the outbreak, and a
national campaign has been launched. Given
Brazil’s history of success in organizing such
campaigns, it is likely that the outbreak will be
rapidly contained and that the effort for measles
eradication will be resumed.
Other Viral Diseases
Other viral diseases include AIDS, with more
than 17,000 new cases registered in the last year.
The number of deaths due to AIDS was 30% lower
in the first half of 1997 than in the first half of 1996.
This decrease is attributed to the introduction of
new antiviral drug combinations. The spread of
the AIDS epidemic, particularly into rural areas,
has resulted in coinfections with different
infectious agents, producing a variety of novel
pathologies. Several subtypes of HIV, as well as
novel recombinations, have been reported.
 Enteric transmission of hepatitis continues;
hepatitis A and D comprise most of the cases,
although the peak incidence is now in young
adults rather than in young children. The
incidence of hepatitis B is declining as a result of
vaccination, while that of hepatitis C is
increasing. A high prevalence of hepatitis D
exists in some regions of the Amazon, where in
conjunction with hepatitis B, it is believed to be
the principal cause of Labrea black fever.
Influenza is a major concern. Imported
vaccine is expensive and not generally available,
and the proportion of elderly people (and the
threat for a large-scale epidemic) is increasing.
The vast forests that still cover large areas of
Brazil are home to many known and unknown
viruses. The Evandro Chagas Institute in Belem
alone has isolated more than 183 new
arboviruses. The increasing exploitation of
sylvatic resources put humans in direct contact
with these viruses, but because of inadequate or
nonexistent medical facilities (entire municipali-
ties still lack a single medical doctor), fevers and
even deaths often are not diagnosed or are
misattributed. Among new viruses causing fatal
infections recently discovered in Brazil are Rocio
virus, which causes encephalitis, and Sabiá virus,
which causes hemorrhagic fever. Several cases of
hantavirus infection have also been reported, but
on these and other occasions, the lack of a
biosafety level 4 laboratory in the country
impeded further work.
Bacterial Diseases
Enteric bacterial infections are an important
cause of illness in Brazil. National figures on
prevalence are not available, except for cholera.
However, an alarming increase has been
reported in antibiotic-resistant strains.
Cholera
The cholera epidemic in Brazil started with
the reemergence of the disease in Latin America
in 1991, reached a peak of more than 60,000
confirmed cases and 670 deaths in 1993, and then
declined to 1,000 cases in 1996. In 1997, the
disease resurged with more than 5,000 reported
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of epidemiologic research in cholera caused by its
resurgence led to the discovery of a new biotype of
Vibrio cholerae in the Amazon region. This biotype
is of the O1 serotype; it has distinct multilocus
enzyme electrophoresis and RAPD profiles from
other pathogenic O1 V. cholerae. About 50
isolates have been made from cases of diarrhea in
the upper Amazon (Solimoes) River. The microbe
apparently lacks the principal known virulence
factors (e.g., the toxin gene cassette and the
major colonization factor, TCP); however, some
isolates present a cytotoxic effect for Y-1 cells.
Mycotic Diseases
Fungal infections, including histoplasmosis,
paracoccidioidomycosis,  and cryptococcosis, occur;
however, their cause is often unknown and even if a
diagnosis is made, the diseases are not reported.
Public Health Infrastructure
The emerging infectious disease picture in
Brazil will not change markedly without a
sustained and determined effort to improve the
country’s public health infrastructure. The
existing, generally passive epidemiologic surveil-
lance system produces information that arrives
too late to be effective; however, a number of
measures, if implemented immediately, can
mitigate the impact of any future epidemic: a
containment laboratory (biosafety level 4) that
can handle known and unknown microbes of high
virulence; at least one infirmary, properly designed
and fully equipped, to treat highly contagious and
virulent diseases. The current lack of this facility
poses a great danger to the population should an
outbreak of such a disease occur.
The financial, technical, and human re-
sources needed to activate these measures
already exist. In infectious diseases, Brazil has a
long tradition of fruitful international collabora-
tion that can be tapped for additional support. The
success of national vaccination and sanitation
campaigns in the eradication and control of some
infectious diseases at the beginning of this century
and in more recent times demonstrates that much
can be accomplished. Brazil can become a
successful model for other developing countries.
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